Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: Sadif Analytics Prime
$25.00
Provider: Thomson Reuters StreetEvents
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Elekta AB Receives Order from Hopital Riviera in Switzerland


Wednesday, 27 Mar 2013 02:30am EDT 

Elekta AB announced that Hopital Riviera has ordered linear accelerator with versatility to treat wide range of cases, from basic to complex. Cancer patients referred to Hopital Riviera’s (Vevey, Switzerland) radiotherapy clinic will soon benefit from the center’s acquisition of Elekta’s new linear accelerator, Versa HD. The system, which is being installed, will be the centerpiece of Hopital Riviera’s modern radiotherapy department, which is scheduled to begin patient treatments in June 2013. Hopital Riviera will maintain its collaborative clinical operations with Center Hospitalier Universitaire Vaudois (CHUV, Lausanne). Hopital Riviera selected custom technology configurations for its Versa HD to support the requirements of treating breast and prostate cancers. Both packages are supported by Elekta’s Clarity soft tissue visualization system to precisely define and target disease sites without invasive marker implants or the added ionizing radiation that some types of imaging require. 

Company Quote

71.7
2.7 +3.91%
5:24am EDT